![CAS No 674792-08-6 4-BOC-4,7-DIAZASPIRO[2.5]OCTANE Pharmaceutical Intermediates](https://ecdn6.globalso.com/upload/p/2209/image_other/2025-04/674792-08-6-4-boc-4-7-diazaspiro-2-5-octane-structure.png)
0102030405
CAS No.1516887-33-4 Pharmaceutical Intermediates
02
introduce
Etoricoxib intermediate is an important component used in the pharmaceutical industry to synthesize etoricoxib, a nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic and antipyretic properties. Our factory integrates production and trading to ensure the highest quality standards and reliable supply of etocoxib intermediates to meet the diverse needs of pharmaceutical manufacturers.
02
Physical and chemical properties
- Etoricoxib intermediates have high purity and precise composition, ensuring consistent performance during etoricoxib synthesis.
- The product's stability and solubility make it suitable for use in pharmaceutical formulations, helping to improve the efficacy and quality of the final drug product.
- Its unique chemical properties and molecular structure make it an important intermediate in the production of etoricoxib, a drug widely used to treat pain and inflammation.
- Our Etoricoxib intermediates are known for their superior quality and reliability, meeting the stringent requirements of the pharmaceutical industry.
- The comprehensive production and trading capabilities of our factory ensure the continuous supply and timely delivery of etocoxib intermediates.
- We prioritize customer satisfaction and offer competitive prices, making our products a cost-effective and reliable choice for pharmaceutical manufacturers.
Etoricoxib intermediates play a vital role in the pharmaceutical industry and are key components in the synthesis of etoricoxib. This NSAID is widely used to treat a variety of conditions, including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain. Pharmaceutical manufacturers rely on our high-quality intermediates to ensure the effectiveness, safety and consistency of final etoricoxib formulations, thereby improving the overall quality of patient care.
In summary, etoricoxib intermediates are an important part of the pharmaceutical industry with exceptional quality, reliability and versatility. With our comprehensive manufacturing and trading capabilities, we are committed to meeting the diverse needs of pharmaceutical manufacturers by providing quality intermediates that meet the highest standards of excellence.